doi:10.1001/jamainternmed.2024.2525 9.Meng Z, Yang M, Wen H, Zhou S, Xiong C, Wang Y
Ipamorelin, as mentioned, is a selective growth hormone secretagogue that prompts the pituitary gland to release growth hormone while primarily affecting the ghrelin receptor
Quick Takeaways Retatrutide is a triple-receptor agonist (GLP-1, GIP, glucagon) delivering superior monotherapy weight loss at 2428.7% over 4868 weeks Cagrilintide targets amylin receptors for satiety and gastric emptying, achieving 10.8% weight loss in 26 weeks as a monotherapy Retatrutide provides broader metabolic benefits, including dramatic improvements in HbA1c, blood pressure, waist circumference, insulin sensitivity, and liver fat normalization No head-to-head trials exist yet, but the mechanistic and clinical data strongly favor Retatrutide for total body recomposition Retatrutide vs Cagrilintide: Side-by-Side Comparison What Makes Retatrutide Different Retatrutide isnt just another GLP-1 receptor agonist
Which GLP-1 drug is most popular in India